Subscribe to RSS
DOI: 10.1055/s-0028-1087818
Synthesis of 3,6-Divinyl-1,2,4,5-Tetrazine, the First Member of the Elusive Vinyltetrazine Family
Publication History
Publication Date:
16 February 2009 (online)

Abstract
The synthesis of the first vinyltetrazine derivative is described. 3,6-Divinyl-1,2,4,5-tetrazine was obtained following a methodology involving cyclization from an imidate and use of 2-phenylsulfonylethyl groups as masked vinyl entities. The first properties of this unique compound are reported.
Key words
azo compounds - condensation - cyclizations - fused ring systems - heterocycles
- 1
Kizhnyaev VN.Vereshchagin LI. Russ. Chem. Rev. 2003, 72: 143 ; and references cited therein -
2a
Kizhnyaev VN.Pokatilov FA.Tsypina NA.Ratovskii GV.Vereshchagin LI.Smirnov AI. Russ. J. Org. Chem. 2002, 38: 1056 -
2b
Wouters G.Smets G. Makromol. Chem. 1982, 183: 1861 -
2c
Attaryan OS.Asratyan GV.Eliazyan GA.Darbinyan EG.Matsoyan SG. Arm. Khim. Zh. 1986, 39: 630 -
2d
Toppet S.Wouters G.Smets G. J. Polym. Sci. Polym. Lett. 1976, 14: 389 -
3a inventors; GB 935787. American
Cyanamid Company;
-
3b
Schaefer FC, andPeters GA. inventors; US 2845422. -
3c
Yuki Y.Kakurai T.Nogushi T.Hiramatsu N. Kobunshi Kugaku 1969, 26: 134 -
3d
Yuki Y.Kakurai T.Nogushi T. Kobunshi Kugaku 1969, 26: 141 -
3e
Overberger CG.Shapiro SL. J. Am. Chem. Soc. 1954, 76: 1061 -
3f
Fukui K,Kitano H,Mizuta M,Osaka T, andKanai K. inventors; JP 44025793. -
4a
Audebert P.Sadki S.Miomandre F.Clavier G. Electrochem. Commun. 2004, 6: 144 -
4b
Topp KD.Grote M. React. Funct. Polym. 1996, 31: 117 -
4c
Zhang BW.Fischer K.Bieniek D.Kettrup A. React. Funct. Polym. 1994, 24: 49 -
4d
Stoicescu-Crivetz L.Mantaluta E.Neamtu G.Zugravescu I. J. Polym. Sci., Part C: Polym. Symp. 1969, 22: 761 -
4e
Stoicescu-Crivetz L.Mantaluta E.Neamtu G.Zugravescu I. Rev. Roum. Chim. 1966, 11: 1127 -
4f
Konishi K,Kobota J,Kotone A, andNakane Y. inventors; JP 7234499. -
5a
Hamasaki A.Ducray R.Boger DL. J. Org. Chem. 2006, 71: 185 -
5b
Soenen DR.Zimpleman JM.Boger DL. J. Org. Chem. 2003, 68: 3593 -
5c
Wan ZK.Woo GHC.Snyder JK. Tetrahedron 2001, 57: 5497 -
5d
Kotschy A.Novák Z.Vincze Z.Smith DM.Hajós G. Tetrahedron Lett. 1999, 40: 6313 -
5e
Seitz G.Overheu W. Arch. Pharm. 1977, 310: 936 -
6a
Chavez DE.Hiskey MA.Gilardi RD. Org. Lett. 2004, 6: 2889 -
6b
Talawar MB.Sivabalan R.Senthilkumar N.Prabhu G.Asthana SN. J. Hazard. Mater. 2004, 113: 11 -
6c
Pagoria PF.Lee GS.Mitchell AR.Schmidt RD. Thermochim. Acta 2002, 384: 187 -
6d
Oxley JC.Smith JL.Chen H. Thermochim. Acta 2002, 384: 91 -
6e
Chavez DE.Hiskey MA.Gilardi RD. Angew. Chem. Int. Ed. 2000, 39: 1791 - 7
Kotone A, andHoda M. inventors; JP 24002. - 8
Tsuda S,Manabe Y, andTsuji K. inventors; JP 107254. - 9
Audebert P.Sadki S.Miomandre F.Clavier G.Vernières M.-C.Saoud M.Hapiot P. New J. Chem. 2004, 28: 387 -
10a
Rao GW.Hu WX. Bioorg. Med. Chem. Lett. 2005, 15: 3174 -
10b
Hu WX.Rao GW.Sun YQ. Bioorg. Med. Chem. Lett. 2004, 14: 1177 - 11
Boger DL.Coleman RS.Panek JS. J. Org. Chem. 1985, 50: 5377 - 13
Alphonse FA.Suzenet F.Keromnes A.Lebret B.Guillaumet G. Org. Lett. 2003, 5: 803 - 14
Sandstrom J. Acta Chem. Scand. 1961, 15: 1575 - 15
Lim CL.Pyo SH.Kim TY.Yim ES.Han BH. Bull. Korean Chem. Soc. 1995, 16: 374 -
16a
Simpkins NS. In Sulfones in Organic Synthesis Vol. 10:Baldwin JE.Magnus PD. Tetrahedron Org. Chem. Series, Pergamon Press; Oxford: 1993. -
16b
Julia M.Arnould D. Bull. Soc. Chim. Fr. 1973, 2: 746 -
16c
Colter AK.Miller RE. J. Org. Chem. 1971, 36: 1898 -
16d
Hwang SH.Kurth MJ. Tetrahedron Lett. 2002, 43: 53 -
16e
Giovannini R.Marcantoni E.Pietrini M. Tetrahedron Lett. 1998, 39: 5827 -
16f
Baker-Glenn CAG.Barrett AGM.Gray AA.Procopiou PA.Ruston M. Tetrahedron Lett. 2005, 46: 7427 - 17
Renard M.Ghosez LA. Tetrahedron 2001, 57: 2597 - 18
Sooducho J.Doskocz J.Cabaj J.Roszak S. Tetrahedron 2003, 59: 4761 -
19a
Weintraub L.Oles SR.Kalish N. J. Org. Chem. 1968, 33: 1679 -
19b
Butler RCM.Chapleo CB.Myers PL.Welburn AP. J. Heterocycl. Chem. 1985, 22: 177 - 22
Comprehensive
Heterocyclic Chemistry II
Vol. 6:
Katritzky AR.Rees CW.Scriven EFV. Pergamon Press; Oxford: 1996. p.949 - 23
Panek JS.Zhu B. Tetrahedron Lett. 1996, 37: 8151
References and Notes
Lithium aluminium hydride, sodium borohydride, or diisobutylaluminium hydride led to major decomposition regardless of the conditions used.
20
Ethyl 3-Phenylsulfanylpropionimido
Ester Hydrochloride (2)
A
steady stream of gaseous HCl was bubbled at r.t. for 10 h through
a stirred EtOH solution (7.3 mL, 0.125 mol) of propionitrile 1 (2.02 g, 12.3 mmol). A white powder gradually
precipitated. The solvent was removed under vacuum, and the crude
precipitate was triturated three times with anhyd Et2O
and finally filtered leading to compound 2 as
a white powder (94% yield); mp 74-75 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 12.50 (s,
1 H), 11.60 (s, 1 H), 7.41-7.27 (m, 5 H), 4.56 (q, J = 6.9 Hz,
2 H), 3.30 (t, J = 6.6
Hz, 2 H), 3.06 (t, J = 6.6
Hz, 2 H), 1.44 (t, J = 6.9
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3): δ = 177.0,
133.7, 130.9, 129.1, 126.4, 70.9, 33.4, 28.8, 13.4. IR (KBr): νmax = 3078,
2951, 1692, 1384, 975 cm-¹. LC-MS (AP+,
MeCN-H2O, 80:20): 2.67 min, 246.7 [M + 1] and
210.3 [M - Cl]. HRMS (FI): m/z calcd for C11H15ONS [M - HCl]:
209.0874; found: 209.0875.
General Cyclization
Procedure
Imidoester hydrochloride 2 (6.17
g, 25.1 mmol) was dissolved in EtOH (0.16 M) under a nitrogen atmosphere, and
the solution was brought to -10 ˚C. Then,
Et3N and N2H4˙H2O
(2.5 mL, 51.4 mmol) were successively added to the solution and
the mixture was allowed to stir (conditions: see Table
[¹]
). The mixture was concentrated
under vacuum, and the slightly pink crude solid obtained was further dissolved
in EtOAc and washed with H2O. The aqueous layer was then
extracted with EtOAc, and the resulting organic layer was washed
with brine, dried over MgSO4, filtered, and concentrated
under vacuum. Depending on reaction conditions the products could
be obtained. Compound 5 was isolated after
simple precipitation from cyclohexane, whereas 3, 4, and 6 were
obtained after chromatography over SiO2 (cyclohexane-EtOAc,
7:1).
N′-[1-Amino-3-(phenylsulfanyl)propylid-1-ene]-3-(phenylthio)propanehydrazonamide (3)
Mp 75 ˚C
(white crystals). ¹H NMR (400 MHz, CDCl3): δ = 7.88-7.15
(m, 10 H), 5.43 and 5.09 (br s, 4 H), 3.24 (t, J = 7.4
Hz, 4 H), 2.55 (t, J = 7.4
Hz, 4 H). ¹³C NMR (100 MHz, CDCl3): δ = 155.8,
135.5, 129.5, 129.0, 126.3, 32.9, 30.8. IR (KBr): νmax = 3450,
3337, 3060, 2960, 1633, 1583, 1482, 1444, 1356, 1287, 910 cm-¹.
LC-MS (AP+, MeCN-H2O, 80:20):
3.40 min, 358.9.
3,6-Bis-(2-phenylsulfanylethyl)-1,2-dihydro-1,2,4,5-tetrazine (4)
Mp 151 ˚C
(white crystals); ¹H NMR (400 MHz, DMSO-d
6
): δ = 7.96
(s, 2 H), 7.37-7.26 (m, 8 H), 7.24-7.12 (m, 2 H),
3.10 (t, J = 7.6
Hz, 4 H), 2.30 (t, J = 7.6
Hz, 4 H). ¹³C NMR (100 MHz, DMSO-d
6
): δ = 148.5,
135.7, 129.1, 128.1, 125.7, 29.8, 28.2. IR: νmax = 3243,
3054, 1677, 1575, 1476, 1436, 1400, 1287, 1257, 1242, 1208, 1165,
1086, 1020 cm-¹. LC-MS (AP+,
MeCN-H2O, 50:50): 7.15 min, 356.9.
4-Amino-3,5-bis(2-phenylsulfanylethyl)-1,2,4-triazole (5)
Mp 80-82 ˚C
(white crystals). ¹H NMR (400 MHz, DMSO-d
6
): δ = 7.40-7.16
(m, 10 H), 5.63 (s, 2 H), 3.31 (t, J = 7.0 Hz,
4 H), 2.98 (t, J = 7.0
Hz, 4 H). ¹³C NMR (100 MHz, CDCl3): δ = 153.5,
134.9, 129.0, 128.9, 126.3, 31.4, 24.6.
IR (KBr): νmax = 3444,
3042, 2991, 1633, 1583, 1482, 1438, 1231, 1205, 790 cm-¹.
LC-MS (AP+, MeCN-H2O, 80:20): 2.49
min, 356.6 [MH+]. Anal Calcd
for C18H20N4S2: C, 60.64;
H, 5.65; N, 15.72; S, 17.93. Found: C, 60.31; H, 5.81; N, 15.67;
S, 17.71.
3,6-Bis(2-phenylsulfanylethyl)-1,2,4,5-tetrazine (6)
Mp 55 ˚C
(pink crystals). ¹H NMR (400 MHz, CDCl3): δ = 7.42-7.35
(m, 4 H), 7.32-7.25 (m, 4 H), 7.24-7.17 (m, 2
H), 3.60 (t, J = 6.8
Hz, 4 H), 3.52 (t, J = 6.8
Hz, 4 H). ¹³C NMR (100 MHz, CDCl3): δ = 168.4,
134.5, 130.5, 129.0, 126.7, 34.7, 31.8. IR (KBr): νmax = 3023,
2406, 1520, 1425, 1356, 1218, 1048, 929 cm-¹.
LC-MS (AP+, MeCN-H2O, 80:20): 3.12
min, 355.2 [MH+]. HRMS (CI): m/z calcd for C18H19N4S2 [MH+]:
355.1051; found: 355.1043.
3,6-Bis(2-phenylsulfonylethyl)-1,2,4,5-tetrazine (7) Tetrazine 6 (1.86 g, 5.25 mmol) was dissolved in CH2Cl2 (0.05 M), and the solution was cooled to -10 ˚C. A solution of MCPBA (5.38 g, 21.8 mmol) in CH2Cl2 (0.25 M) was added over a period of 1 h (the temperature was kept below 0 ˚C), after which TLC analysis indicated completion of the reaction [R f (6) = 0.37 (cyclohexane-EtOAc, 7:1), pink spot; R f (7) = 0 (cyclohexane-EtOAc, 7:1), pink spot]. The mixture was successively washed with a solution of NaHSO3 (10%) and a solution of NaHCO3 (10%). The organic layer was then washed with sat. NaCl solution, dried over MgSO4, and filtered. Product 7 was finally obtained as a pink powder (2.19 g, 100%) after concentration under vacuum; mp 183-185 ˚C. ¹H NMR (400 MHz, DMSO-d 6 ): δ = 7.92-7.88 (m, 4 H), 7.74-7.60 (m, 2 H), 7.71-7.62 (m, 4 H), 3.93 (t, J = 7.6 Hz, 4 H), 3.44 (t, J = 7.6 Hz, 4 H). ¹³C NMR (100 MHz, DMSO-d 6 ): δ = 167.0, 138.2, 134.1, 129.6, 127.9, 51.9, 28.1. IR (KBr): νmax = 3082, 2954, 1448, 1427, 1395, 1310, 1294, 1269, 1148, 1083, 1047, 1033, 996, 980, 906, 778, 745, 711 cm-¹. LC-MS (AP+, MeCN-H2O, 50:50): 5.72 min, 418.9 [MH+]. Anal. Calcd for C18H18N4S2O4: C, 51.66; H, 4.34; N, 13.39. Found: C, 51.98; H, 4.40; N, 13.55. HRMS (CI): m/z calcd for C18H19N4S2O4 [MH+]: 419.0848; found: 419.0854.
253,6-Divinyl-1,2,4,5-tetrazine (8) To a stirred solution of s-tetrazine 7 (600 mg, 1.43 mmol) in dry THF (120 mL) was added KOt-Bu (307 mg, 2.73 mmol) at -20 ˚C for 1.5 h. The reaction was followed by TLC analysis [R f (7) = 0.45 (cyclohexane-EtOAc, 4:6); R f (8) = 0.95 (cyclohexane-EtOAc, 4:6)]. The solution was finally diluted with 150 mL of cooled Et2O, filtered, and washed with a solution of NaHCO3 (10%, 2 × 100 mL). The organic layer was then washed with brine (150 mL), dried over MgSO4, and further concentrated under controlled vacuum because of its volatility. Product 8 was purified over a SiO2 column (pentane-Et2O, 80:20; R f = 0.96), obtained as a dark pink oil (81 mg, 42% yield), and kept in the freezer. ¹H NMR (400 MHz, CD2Cl2): δ = 7.17 (dd, J = 10.8, 17.6 Hz, 2 H), 7.01 (dd, J = 1.2, 17.6 Hz, 2 H), 6.02 (dd, J = 1.2, 10.8 Hz, 2 H). ¹³C NMR (100 MHz, CD2Cl2): δ = 164.2, 131.0, 127.8. IR (KBr): νmax = 3041, 1632, 1434, 1364, 1343, 1259, 1075, 1032, 984, 950, 902, 711 cm-¹. LC-MS (AP+, MeOH): 0.04 min, 135.3 [MH+]; HRMS (FI): m/z calcd for C6H6N4 [M+]: 134.0592; found: 134.0590.